Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Ng

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Elife|December 23, 2022
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model developmentPaul R Barber, Rami Mustapha, Fabian Flores-Borja, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2021
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosisShih-Hsin Chen, Kenneth Miles, Stuart A Taylor, et al.
BMC Medical Imaging|November 16, 2019
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancerSola Adeleke, Arash Latifoltojar, Harbir Sidhu, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2018
Corrigendum: Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline <i>CHEK2</i>:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinomaMy Linh Thibodeau, Caralyn Reisle, Eric Zhao, et al.
JCO Precision Oncology|August 3, 2019
Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed CancerYulia Newton, S Rod Rassekh, Rebecca J Deyell, et al.
Science Signaling|March 27, 2014
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancerJessica J Tao, Pau Castel, Nina Radosevic-Robin, et al.
Cold Spring Harbor Molecular Case Studies|May 18, 2017
Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline <i>CHEK2</i>:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinomaMy Linh Thibodeau, Caralyn Reisle, Eric Zhao, et al.
Developmental Cell|July 13, 2023
LYVE-1<sup>+</sup> macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancerJoanne E Anstee, Karen T Feehan, James W Opzoomer, et al.
Cell Reports|July 19, 2018
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 PresentationJames Monypenny, Hanna Milewicz, Fabian Flores-Borja, et al.
Histopathology|August 24, 2017
Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusionMeng K Wong, Cedric C Y Ng, Chik H Kuick, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Elife|December 23, 2022
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model developmentPaul R Barber, Rami Mustapha, Fabian Flores-Borja, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2021
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosisShih-Hsin Chen, Kenneth Miles, Stuart A Taylor, et al.
BMC Medical Imaging|November 16, 2019
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancerSola Adeleke, Arash Latifoltojar, Harbir Sidhu, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2018
Corrigendum: Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline <i>CHEK2</i>:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinomaMy Linh Thibodeau, Caralyn Reisle, Eric Zhao, et al.
JCO Precision Oncology|August 3, 2019
Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed CancerYulia Newton, S Rod Rassekh, Rebecca J Deyell, et al.
Science Signaling|March 27, 2014
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancerJessica J Tao, Pau Castel, Nina Radosevic-Robin, et al.
Cold Spring Harbor Molecular Case Studies|May 18, 2017
Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline <i>CHEK2</i>:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinomaMy Linh Thibodeau, Caralyn Reisle, Eric Zhao, et al.
Developmental Cell|July 13, 2023
LYVE-1<sup>+</sup> macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancerJoanne E Anstee, Karen T Feehan, James W Opzoomer, et al.
Cell Reports|July 19, 2018
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 PresentationJames Monypenny, Hanna Milewicz, Fabian Flores-Borja, et al.
Histopathology|August 24, 2017
Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusionMeng K Wong, Cedric C Y Ng, Chik H Kuick, et al.
Pageof 20